Declining MacBook sales has Apple considering a budget option, says Kuo

apple macbook air 15 inch lid
Credit: Ryan Haines / Android Authority
  • Apple is rumored to be working on a more affordable version of the MacBook that would compete with Chromebooks.
  • Apple analyst Ming-Chi Kuo says the company is considering that option, but hasn’t decided yet.
  • Making a cheaper MacBook may be a move to combat declining MacBook sales.

In early September, it was reported that Apple may be working on a more affordable version of the MacBook. This cheaper MacBook model would be in direct competition with some of the best Chromebooks. Now Apple analyst Ming-Chi Kuo says the move may be motivated by declining MacBook sales.

On X (formerly Twitter), Kuo states that Apple has seen a significant decline in MacBook sales in 2023. The analyst claims that Apple attributes the drop to the M2 chip, which only provides a small upgrade compared to the performance of the M1. He also suggests that the reason Apple is holding an event at the end of the month is to launch a much more powerful M3 series MacBook Pro, in hopes of boosting shipments, despite low production volume.



from Android Authority https://ift.tt/K6tWpnI
via IFTTT

Comments

Post a Comment

Popular posts from this blog

6 investors discuss why AI is more than just a buzzword in biotech

As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. “Most of the companies we have seen have an AI component to support the discovery or development processes,” Francisco Dopazo, a general partner at Humboldt Fund told TechCrunch recently. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations. So to get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today. For Franck Lescure, a partner at Elaia Partners, in biotech, having an AI component isn’t an automatic deal closer. “We do not favor biotech startups with extant AI over those without: Bio-revolution is not only digital. Digital is one tool; the other major tool is the livin
Read more

Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures (Igor Bosilkovski/Forbes)

Image
Igor Bosilkovski / Forbes : Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures   —  Canadian collaborative conversational AI tool Voiceflow announced today that it has raised $20 million in a Series A round led by Felicis Ventures. from Techmeme https://ift.tt/3rFQ9St via IFTTT
Read more

Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics (Adam Rawnsley/Rolling Stone)

Image
Adam Rawnsley / Rolling Stone : Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics   —  Elon's mass firing of security staff and increased reliance on automation is going to make it easier for tyrants to shout … from Techmeme https://ift.tt/xQsF2ef via IFTTT
Read more